How To Overcome Three Challenges Facing Biotech Companies In 2021
Velocity Global
MARCH 26, 2021
Biotech and life sciences firms experienced a banner year in 2020. The COVID-19 pandemic highlighted the value of innovative medical solutions, leading to new opportunities for research, product approval, and funding. . The FDA greenlit more medicines than it did in any year other than 1996. Biotech IPOs set records in both deals (74) and total value (over $14 billion).
Let's personalize your content